Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) Return on Capital Employed (2021 - 2026)

RxSight filings provide 5 years of Return on Capital Employed readings, the most recent being 2.88% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed fell 88.0% to 2.88% in Q4 2025 year-over-year; TTM through Dec 2025 was 2.88%, a 88.0% decrease, with the full-year FY2025 number at 2.83%, down 26.0% from a year prior.
  • Return on Capital Employed hit 2.88% in Q4 2025 for RxSight, up from 5.02% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.28% in Q3 2024 to a low of 46.66% in Q4 2022.
  • Median Return on Capital Employed over the past 5 years was 17.27% (2021), compared with a mean of 19.5%.
  • Biggest five-year swings in Return on Capital Employed: plummeted -1846bps in 2022 and later skyrocketed 4033bps in 2023.
  • RxSight's Return on Capital Employed stood at 28.21% in 2021, then plummeted by -65bps to 46.66% in 2022, then skyrocketed by 86bps to 6.33% in 2023, then skyrocketed by 68bps to 1.99% in 2024, then plummeted by -44bps to 2.88% in 2025.
  • The last three reported values for Return on Capital Employed were 2.88% (Q4 2025), 5.02% (Q3 2025), and 3.93% (Q2 2025) per Business Quant data.